CHI Advisors LLC 13D/13G Filings for Corvus Pharmaceuticals, Inc. (CRVS)

CHI Advisors LLC 13D and 13G filings for Corvus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-13
12:01 pm
Purchase
2022-12-31 13G Corvus Pharmaceuticals, Inc.
CRVS
CHI Advisors LLC 2,384,402
5.120%
2,384,402increase
(New Position)
Filing